Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tetrahydromagnolol C5552: Assay Reliability Guide
2026-08-31
This scenario-based guide explains how Tetrahydromagnolol (SKU C5552) can be incorporated into CB2 receptor, cell viability, and GPCR signaling workflows. It connects receptor potency, solvent selection, storage, dose interpretation, and vendor evaluation to practical laboratory decisions without equating receptor activity with cytotoxicity.
-
Phosphatase Inhibitor Cocktail 1: Lab Guide
2026-08-30
Learn how Phosphatase Inhibitor Cocktail 1 (100X in DMSO), SKU K1012, supports phosphorylation state preservation during cell and tissue lysate preparation. This scenario-based guide connects inhibitor selection with reproducible viability, proliferation, cytotoxicity, Western blot, and phosphoproteomic workflows.
-
LY2886721: A Practical BACE Inhibitor Workflow
2026-08-29
LY2886721 combines nanomolar BACE1 inhibition with a practical path from APP-processing assays to oral PDAPP mouse studies. This guide emphasizes partial amyloid beta reduction, matched synaptic readouts, solution handling, and troubleshooting for reproducible Alzheimer’s disease research.
-
Ibuprofen in Colon Cancer Assay Design
2026-08-28
Ibuprofen is more than a COX inhibitor in experimental oncology: its activity depends on cellular context, protein binding, and assay design. This guide connects 2-[4-(2-methylpropyl)phenyl]propanoic acid to orthogonal colon cancer research workflows and interprets the mechanistic lessons of a key drug–albumin study.
-
Meropenem as a Resistance-Aware Research Tool
2026-08-28
Meropenem is more than a broad-spectrum comparator: its PBP-directed mechanism, susceptibility to carbapenemase-mediated resistance, and utility in infection models make it a powerful translational research tool. This article connects Meropenem pharmacology with plasmid-borne resistance, gene transmission, assay design, and formulation strategy, using recent carbapenem-resistant Enterobacter cloacae data to define a resistance-aware experimental framework.
-
Prednisone: From Immune Mechanism to Translation
2026-08-27
A mechanism-first framework for using Prednisone to model lymphocyte suppression, validate apoptosis, manage exposure variables, and translate findings without overextending evidence from botanical metabolomics.
-
5-Azacytidine: Assay Design for Epigenetic Response
2026-08-27
Explore how 5-Azacytidine converts DNA methylation biology into testable assay logic, with a focus on PTEN-deficient glioblastoma, viral mimicry, resistance-aware controls, and practical workflow design.
-
Mycophenolic acid: Reliable Assay Workflows
2026-08-26
Learn how Mycophenolic acid (SKU B1981) can improve interpretation of proliferation, viability, and immunometabolism assays through controlled nucleotide-biosynthesis perturbation. This scenario-based guide covers stock preparation, whole-blood compatibility, controls, data interpretation, and practical supplier selection.
-
CAR Charge Density, Tonic Signaling, and T-Cell Fitness
2026-08-26
The reference study identifies positively charged patches on CAR antigen-binding domains as a structural driver of receptor clustering and ligand-independent tonic signaling. Its results show that reducing or increasing these local electrostatic features can tune CAR-T exhaustion, persistence, and antitumor activity without sacrificing antigen affinity or specificity.
-
From dNTP Control to LNP Translation
2026-08-25
A translational framework for using a defined 10 mM dNTP mixture to improve DNA synthesis workflows while interpreting lipid nanoparticle trafficking data with greater mechanistic discipline.
-
GM 6001 (Galardin) in ECM Workflows
2026-08-25
GM 6001, also called Galardin, gives researchers a nanomolar-range way to interrogate MMP-dependent extracellular matrix remodeling across neural, tissue-repair, cancer, and vascular models. This practical guide connects target engagement, assay design, dosing, controls, and troubleshooting without confusing broad MMP inhibition with a disease-specific treatment.
-
Agatoxin-Sensitive Calcium Channels in Cardiac Vagal Neurons
2026-08-24
Wang, Irnaten, and Mendelowitz used whole-cell patch-clamp recordings to show that agatoxin-IVA-sensitive voltage-dependent calcium channels are central to nicotine-evoked presynaptic and postsynaptic activation of cardiac vagal neurons. Their pharmacological comparison separates a calcium-dependent ligand-gated inward current from L-type-sensitive facilitation of glutamatergic miniature events, providing a useful framework for interpreting calcium signaling in autonomic circuits.
-
Doxycycline: Workflows for MMP and Cancer Research
2026-08-24
Doxycycline supports parallel antimicrobial, metalloproteinase, and cancer-cell workflows, but its water insolubility makes stock preparation and vehicle controls central to reproducibility. This guide translates an MMP2-responsive peptide-delivery study into practical assay designs without confusing doxycycline with the study’s doxorubicin payload.
-
TG003: Cdc2-like Kinase Inhibitor Workflow
2026-08-23
TG003 enables controlled interrogation of Clk-dependent phosphorylation, alternative splicing, and exon choice in cell and biochemical assays. Its value extends to translational studies of platinum resistance, but its multi-Clk and CK1 activity makes orthogonal validation essential.
-
Sulfo-NHS-LC-Biotin: Practical Labeling Guide
2026-08-22
Sulfo-NHS-LC-Biotin is a water-soluble reagent for stable covalent biotinylation of primary amines on proteins, peptides, and intact-cell surface proteins. It is suited to downstream biotin-avidin detection or streptavidin capture, but not to reversible or intracellular labeling under intact-cell conditions.